A systematic approach to stabilizing EBA-175 RII-NG for use as a malaria vaccine. (Q48030185)

7 February 2018

title

A systematic approach to stabilizing EBA-175 RII-NG for use as a malaria vaccine. (English)

1 reference

7 February 2018

0 references

1 reference

Laura J Peek

1

1 reference

7 February 2018

Duane T Brandau

2

1 reference

7 February 2018

LaToya S Jones

3

1 reference

7 February 2018

Sangeeta B Joshi

4

1 reference

7 February 2018

C Russell Middaugh

5

1 reference

7 February 2018

language of work or name

English

0 references

publication date

12 May 2006

1 reference

7 February 2018

number of pages

13

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

7 February 2018

volume

24

1 reference

7 February 2018

issue

31-32

1 reference

7 February 2018

page(s)

5839-5851

1 reference

7 February 2018

Progress and challenges for malaria vaccines

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.067

The cytoplasmic domain of the Plasmodium falciparum ligand EBA-175 is essential for invasion but not protein trafficking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.067

Research toward malaria vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.067

A Plasmodium falciparum antigen that binds to host erythrocytes and merozoites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.067

Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.067

Primary structure of the 175K Plasmodium falciparum erythrocyte binding antigen and identification of a peptide which elicits antibodies that inhibit malaria merozoite invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.067

Conservation of structure and function of the erythrocyte-binding domain of Plasmodium falciparum EBA-175.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.067

Analysis of the thermal and pH stability of human respiratory syncytial virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.067

Solution behavior of IFN-beta-1a: an empirical phase diagram based approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.067

Anthrax vaccine powder formulations for nasal mucosal delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.067

Derivative absorbance spectroscopy and protein phase diagrams as tools for comprehensive protein characterization: a bGCSF case study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.067

Effect of pH and ionic strength on the physical stability of adenovirus type 5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.067

Thermal stability of vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.067

Calculation of protein extinction coefficients from amino acid sequence data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.067

Simultaneous monitoring of the environment of tryptophan, tyrosine, and phenylalanine residues in proteins by near-ultraviolet second-derivative spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.067

Structural basis for the EBA-175 erythrocyte invasion pathway of the malaria parasite Plasmodium falciparum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.067

Alpha-Lactalbumin: compact state with fluctuating tertiary structure?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.067

‘Molten‐globule state’: a compact form of globular proteins with mobile side‐chains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.067

Partially structured self-associating states of acidic fibroblast growth factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.067

Mutations that significantly change the stability, flexibility and quaternary structure of the l-lactate dehydrogenase from Bacillus megaterium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.067

The interaction of a naphthalene dye with apomyoglobin and apohemoglobin. A fluorescent probe of non-polar binding sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.067

1-Anilino-8-naphthalene sulfonate anion-protein binding depends primarily on ion pair formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.067

Aluminum salts in vaccines--US perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.067

Mechanisms of stimulation of the immune response by aluminum adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.067

Aluminium compounds for use in vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.067

Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.067

Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.067

Predicting the adsorption of proteins by aluminium-containing adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.067

Contribution of electrostatic and hydrophobic interactions to the adsorption of proteins by aluminium-containing adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.067

Mechanism of adsorption of hepatitis B surface antigen by aluminum hydroxide adjuvant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.067

Effects of adsorption to aluminum salt adjuvants on the structure and stability of model protein antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.067

10.1016/J.VACCINE.2006.04.067

7 January 2021

Identifiers

DOI

1 reference

7 February 2018

PubMed ID

16735084

1 reference

7 February 2018